A daily pill that has been shown to double the chances of quitting smoking will launch in the UK next week, backed by £70 million ($89 million) in government funding for c
Daniel Ghinn reviews the online commentary among healthcare professionals following Public Health England’s advice that smokers should be encouraged to take up vaping instead.
While at Reuters Pharma Europe in Barcelona the other week, pharmaphorum web editor Nicole Raleigh spoke with Florian Schnappauf, VP of enterprise commercial strategy at Veeva Europe, about
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.